Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.
The estimated total number of symptomatic VTE events (range based on probabilistic sensitivity analysis) per annum within the six EU countries was 465,715; almost three-quarters of all VTE-related deaths were from hospital-acquired VTE. Expand
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk
Oral but not transdermal ERT is associated with risk of VTE in postmenopausal women, and data suggest that transder mal ERT might be safer than oral ERT with respect to thrombotic risk. Expand
Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study
Oral but not transdermal estrogen is associated with an increased VTE risk, and data suggest that norpregnane derivatives may be thrombogenic, whereas micronized progesterone and pregnane derivatives appear safe with respect toThrombotic risk. Expand
Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.
- E. Oger
- Thrombosis and haemostasis
- 1 May 2000
The incidence of venous thromboembolism rose markedly with increasing age for both sexes; over the age of 75, the annual incidence reached 1 per 100; these results raise concerns on identification of medical patients at high risk and effective prophylaxis. Expand
Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation: Study From the FRANCE 2 Registry
- A. Luçon, E. Oger, +9 authors H. le Breton
- Circulation. Cardiovascular interventions
- 1 April 2014
PH (sPAP ≥40 mm Hg) in patients with aortic stenosis undergoing transcatheter aorti valve implantation was associated with increased 1-year mortality especially when severe but not with increased 30-day mortality, and functional status was significantly improved regardless of PAP level. Expand
Prevention of venous thrombosis in patients with acute intracerebral hemorrhage
Intermittent pneumatic compression significantly decreased the occurrence of asymptomatic deep vein thrombosis (DVT) for patients with intracerebral hemorrhage. Expand
Prothrombotic Mutations, Hormone Therapy, and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration
In contrast to oral estrogen, transdermal estrogen does not confer additional risk on women who carry a prothrombotic mutation, and the safety of transDermal estrogen has to be confirmed in randomized trials. Expand
Estrogen plus progestin and risk of venous thrombosis.
Influence of the humidification device during acute respiratory distress syndrome
Artificial airway dead-space reduction allows a significant PaCO2 reduction, independently of any respiratory mechanical changes, and this very simple maneuver may be of importance when low tidal volume ventilation is used in ARDS patients, and when Pa CO2 lowering is warranted. Expand
Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients.
The findings in a large series of patients confirm the 20210 A allele prothrombin gene as a risk factor for VTE and suggest that its association with the factor V Leiden is not uncommon. Expand